Search 

Innovation- and award winning smart clothing for hospitalized babies. Saves time for staff, allows parental involvement adding to a speedier recovery. Eliminates contaminations and spread of bacteria becasue cannulas and wires do not need to be detached during clothes change.

Company aim is to produce high- tech medical solutions especially for reliable assessment and training of muscular strength.

Business idea is to offer solutions for safe and rapid recovery of patient’s functional ability in musculoskeletal rehabilitation enabling cost-effectiveness and increasing productivity in primary care profiting both end-user and health care provider.

The team know-how consist professional expertise on exercise physiology, engineering, as well as software and project management. In order to maximize full potential of product commercialization we are looking for complementary core expertise and supportive financing for successful products launch and internationalization efforts. 

Blueprint Genetics provides genetic diagnostics of rare diseases. The products are targeted for healthcare professionals and researchers. We sequence and interpret customers’ samples that are sent to the Blueprint laboratory and we report results online in 21 days after receiving the sample. Blueprint is able to cut the prices of rare diseases genetic testing by 15-70% while increasing quality and providing a statement that is backed with clinical expertise.

Blueprint Genetics was founded during summer 2012 and is currently backed up by angel investors. The company applies a revolutionary targeted DNA sequencing method developed in Stanford and published in the Nature. The company has just launched its first ten products and started the sales of clinical grade diagnostics. The company has an extensive product roadmap covering a long list of different hereditary disease groups. The first products are diagnostics for hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases.

Bone Index Finland Ltd. provides patented, reliable and cost effective solution for the growing need of osteoporosis diagnostics at primary healthcare.

Quality and safety are essential part of our business. Bone Index Finland has ISO 13485 certified Quality System as a medical device manufacturer. Products manufactured by us fulfill the requirements of Medical Device Directive (MDD 93/42/EEC).

It is estimated that over 75% of osteoporotic patients are not diagnosed nor receive treatment for their condition because the diagnostics is done in special healthcare. Our solution to fight this problem, Bindex®, is validated against prevailing gold standard in diagnostics (axial DXA) at special healthcare by using international guidelines. Therefore Bindex® results are comparable to axial DXA.

By using the world’s first pocket size instrument for bone densitometry, Bindex®, the osteoporosis can be diagnosed wherever you want!

Cognuse is developing solutions for the mental healthcare industry.

Our core product platform CognuseManager is an evidence-based patient-centric tool for cognitive rehabilitation in the executive functions domain. It allows TBI and stroke patients to continue their rehabilitation processes in the home setting on most modern devices with a touch screen and gives the therapist an opportunity to monitor their progress in real-time and adjust the training plans, when necessary.

While the initial set of exercises focused on real-life tasks, we are now expanding into other cognitive domains to provide a full suite of services for the rehabilitation flow.

Our customers include hospitals, clinics, independent professionals and home users in neuropsychological rehabilitation, mental healthcare and other related sectors.